Created projects

Live projects

No projects found.

Draft projects

No projects found.

Pending Projects

No projects found.

Membership Projects

No projects found.

Suspended Projects

No projects found.

Expired Projects

    No projects found.

view all

You are logged in as Log out

  • 1

  • $ 10

    pledged of $ 10,000 goal
  • 3656

    days ago
  • Campaign Ended!

    This project was expired.

  • This project was expired on 2014-02-26

About our project

The Problem We Solve

10 billion dollars and 1 million hospital readmissions each year, for 6 million Americans living with Congestive Heart Failure (CHF) are three numbers that are far too high and much of them are preventable. Our innovation addresses this currently high rate of preventable hospital admissions and readmissions. In most instances, CHF patients are advised to take a daily diuretic to manage fluid volume overloading, and measure its effectiveness by using a bathroom scale. If there is an increase of approximately 3 pounds in one day, the patient is advised to go to the hospital.

This method is overly crude, and neglects to monitor the other informative metrics in CHF patients. This causes patients to not only be hospitalized when their conditions do not demand it, but it also fails to detect cases of reversibly insufficient therapy. By monitoring a significantly more extensive set of metrics for CHF we can detect small changes and reverse them before they become deteriorations that require hospitalization.

How We Solve It

What exactly is CHF? When the heart fails to effectively function like a pump, fluids get backed up throughout its circuit (the blood vessels), and the transportation of blood becomes inefficient and even insufficient.

We use a wearable garment with biosensors to measure all the metrics that best indicate progression of CHF – those metrics are in the heart, lungs, blood, and other parts of the body – and the efficacy of its treatment, so that we may make adjustments in therapy BEFORE the patient needs to be admitted to the hospital or go to the emergency department.

How it Works

VoluMonitor works by monitoring the metrics of the heart that indicate the health-state of the patient with CHF. Biosensors are embedded in a vest that the patient wears each day, and that data is sent for analysis to the patient’s doctor, who can determine if the patient is healthy, or needs his or her therapy to be adjusted.

Clinical Proof to Date

We’ve tested our prototypes on healthy test subjects under the conditions of an IRB.

FDA Status

We will be submitting a 510(k) for class 2 device clearance. This means that we will set out to prove to the FDA that our device is, essentially, at least as effective as the current state of the technology used.

How your project will help reduce cardiovascular disease and stroke by 20% by 2020

By closely monitoring the biometrics associated with CHF, we will be able to tailor therapies to match precisely what (and when) patients need. In doing so, we will prevent progression of CHF in diagnosed patients, reduce hospital admissions, maintain a healthy state to prevent catastrophic events (e.g. maintain a normal BP in CHF patients to prevent stroke), and increase patient quality of life.

How We Help Patients

We empower patients to take control of their CHF. Currently, the most a patient can do, usually, is measure his or herself each morning, and determine if the CHF drugs are working. By making a system that both collects all relevant biometrics, and also is extremely comfortable and simple to use, we offer patients a system with high compliance potential, that can better guide them and their doctors in managing their CHF.

How We Help Doctors

Our solution can prevent a significant majority of costly (and penalized under the Affordable Healthcare Act) hospital readmissions for your patients. Our device is relatively low cost, with a monthly service fee, so if you don’t like it, you need not have your patients use it.

How We Help Hospitals, Institutions, and/ or Medical Facilities

By preventing deterioration of CHF patients with monitoring in their own homes, we can prevent most CHF readmissions, keep limited beds open, and prevent heavy penalties to hospitals that have been instated with the Affordable Care Act that penalize for readmissions.

How We Help Our Partners

By preventing deterioration of CHF, we can prevent hospital readmissions. Each hospital readmission costs at least $10,000. We can prevent catastrophic events like stroke, which are most burdensome to insurers. Let’s work together to keep patients healthier and out of the hospital!

How We Will Spend Your Contributions

Perfecting our prototypes for both the patient and the doctor: to maximize comfort and usability for the patient (to optimize patient compliance), and to optimize the management and presentation of the data to the doctor.

Who We Are

We are a young team of engineering, medical, and clnical experts looking to innovate in ways that can improve health and quality of life for cardiac patients.

Founders: Vigi Katlowitz, Eric Forkosh, Larry Baruch, Benji Strauss

Chief Medical Officer: Larry Baruch, MD
Attending cardiogist at New York hospitals. Clinical guru.

CTO / Engineering Lead: Eric Forkosh
Hardware whiz and microprocessor designer. Youngest adjunct prof.

Chief Science Officer: Vigi Katlowitz
Machine learning guru. Cooper Union engineer. Neuro-enthusiast.

Chief Executive Officer: Benji Strauss
Inspired. Cooper Union biomedical engineer. EMT. Inventor. Humbled.

How to Find Us



For $ 50 or more

0 Supporter(s)

DOCTORS: Help your CHF patients stay out of the hospital and increase their quality of life via VoluMonitor. Show the world that you are working to reduce the burden of CHF. In return we will do our best to solve it and know we are doing it for you. Here and on our website, in perpetuity, we will list you and your practice as PIONEER SPONSORS with our sincere thanks. You also get a tax deductible receipt (as you do for all rewards.)

For $ 100 or more

0 Supporter(s)

DOCTORS: All of the above and get the VoluMonitor Scrub set!

For $ 499 or more

0 Supporter(s) Limited (20 left of 20 )

DOCTORS: BECOME a PILOT Site – Once cleared for a Clinical Trial, we will send you 1 complete VoluMonitor unit, as well as a 3 months of complimentary analysis service for that device and patient it who uses it.

For $ 500 or more

0 Supporter(s)

HOSPITALS: Show our community and the whole world that you want to improve quality of life for CHF patients and solve the burdensome CHF readmissions problem. In return we will do our best to solve this and know we are doing it for you. Here and on our website, in perpetuity, we will list you and your practice as INSTITUTIONAL SPONSORS with our sincere thanks.

For $ 1000 or more

0 Supporter(s) Limited (3 left of 3 )

HOSPITALS: All of the above and get 25 Scrubs or polo shirts or customized for your hospital to show your patients, colleagues, and the community that you are part of the solution!

For $ 1500 or more

0 Supporter(s) Limited (3 left of 3 )

PARTNERS: Show the world that you want to reduce CHF readmissions and improve quality of life for CHF patients. In return we will do our best to solve it and know we are doing it for you. Here and on our website, in perpetuity, we will list you and your practice as CORPORATE SPONSORS with our sincere thanks.

For $ 2500 or more

0 Supporter(s) Limited (3 left of 3 )

All of the above and get 25 VoluMonitor polo shirts!

    No updates found .

    No comments found .

Login to post your comment!
Click here to Login